You blokes are too tied up in detail.
LTR hasn't scratched the surface of any of these prospects. The company has around 350 initial Tanzanian assays to report on in the near future and yet you've already wiped of any prospect for discovery and accelerated to production - likely in NT because Tanzania is a waste of time - in your view.
LTR will be traded hard on assay results over the near future and then traded hard on whatever they do in the NT. It's way too early to picture the company in production as you guys seem to be doing. That may take a little longer.
Ann: Investor Presentation March 2016, page-12
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LTR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.00 |
Change
0.035(3.63%) |
Mkt cap ! $2.425B | |||
| Open | High | Low | Value | Volume |
| 97.5¢ | $1.02 | 97.0¢ | $15.30M | 15.33M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 92465 | $1.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.01 | 20810 | 3 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| LTR (ASX) Chart |